ACSL4 and neoplasm: Based on these studies, it is believed that increasing the enzymatic activity of ACSL4 will provide sufficient 'fuel' for LPO, which, in conjunction with the abundant ROS generated by SDT, could trigger effective ferroptosis tumor therapy.